MedTrace Logo

Behavioral Pharmacology of THC and Alpha-pinene

NCT04130633 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 33

Last updated 2025-05-22

Study results available
· View outcomes & findings →

Summary

This study will evaluate the pharmacokinetics and pharmacodynamics of vaporized alpha-pinene and THC administered via inhalation.

Conditions

  • THC
  • Alpha-pinene

Interventions

DRUG

Placebo

Placebo vapor (distilled water)

DRUG

THC

Pure THC vapor

DRUG

Alpha-Pinene

Pure alpha-pinene vapor

Sponsors & Collaborators

Principal Investigators

  • Ryan Vandrey, PhD · Johns Hopkins University

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-11-05
Primary Completion
2024-03-08
Completion
2024-03-08
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04130633 on ClinicalTrials.gov